Cancer Research

 
Stock Quotes for Cancer Research top ^
  • Industry: Health Information Services
  • Sector: Technology
  • Stock Type: Distressed
Sign-up for cthz investment picks

 
News Articles for Cancer Research top ^
World-renowned cancer centers and Illumina, Inc. (NASDAQ:ILMN) today announced the formation of the Actionable Genome Consortium (AGC), an effort to recommend openly published standards for the widespread use of next-generation sequencing to guide decision-making in clinical oncology.
Sign-up for Actionable Genome Consortium Forms with Cross Disciplinary Leaders from World-Renowned Cancer Institutions investment picks
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced publication of an article titled “FAK Inhibitor Kills Mesothelioma Cells” in Cancer Discovery , a medical journal published by the American Association for Cancer Research (AACR). The commentary references preclinical scientific data on targeting mesothelioma cancer stem cells through inhibition of focal adhesion kinase (FAK) that was recently published in Science Translational Medicine (Vol. 6, Issue 237, p.237ra68). Two of Verastem’s lead drug candidates, VS-6063 and VS-4718, target cancer stem cells through potent inhibition of FAK.
Sign-up for The Potential of Targeting Cancer Stem Cells Through FAK Inhibition in Mesothelioma Reported in AACR’s Cancer Discovery investment picks
2014/9/2
Today, Siemens reached the millionth pass of the Baton through “The Baton Pass™” – an effort to raise money for innovative cancer research programs and to spread a message of hope and unity.
Sign-up for Siemens Achieves Goal of One Million Passes Through The Baton Pass™ Campaign; $1 Million to be Donated to Stand Up To Cancer® to Support Accelerated Research investment picks
Polaris Industries Inc. (NYSE: PII), the leading manufacturer of off-road vehicles, today announced the company has donated a customized pink RZR XP 1000 to the American Cancer Society as part of their Making Strides Against Breast Cancer campaign.
Sign-up for Polaris Donates Customized RZR XP 1000 to Raise Funds for the American Cancer Society investment picks
PRINCETON, N.J., June 16, 2014 (GLOBE NEWSWIRE) -- Advaxis, Inc. (Nasdaq:ADXS) , a clinical-stage biotechnology company developing cancer immunotherapies, announced that the Georgia Regents University (GRU) Cancer Center has received Institutional Review Board (IRB) approval to initiate a Phase 1/2 trial evaluating higher doses and repeat cycles of ADXS-HPV in patients with recurrent cervical cancer.
Sign-up for Advaxis Evaluates Higher Dose and Repeat Cycles of ADXS-HPV in Phase 1/2 Cervical Cancer Trial investment picks
2014/7/8
CALGARY , July 8, 2014 /PRNewswire/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced completion of patient enrollment in a two-arm randomized phase II study of carboplatin, paclitaxel plus REOLYSIN ® versus carboplatin and paclitaxel alone in the first line treatment of patients with recurrent or metastatic pancreatic cancer (OSU-10045). The principal investigator is Tanios Bekaii-Saab, MD, associate professor and gastrointestinal oncology section chief at The Ohio State University Comprehensive Cancer Center - Arthur G.
Sign-up for Oncolytics Biotech® Inc. Announces Completion of Patient Enrollment in U.S. Randomized Phase II Pancreatic Cancer Study investment picks
Cancer Genetics Now Positioned to Participate in High-Growth Indian Diagnostics Market, Where More Than 1 Million New Cancer Cases Are Diagnosed Each Year Cancer Genetics Derives Immediate Revenue Through BioServe India's Clients, Which Include Dr.
Sign-up for Cancer Genetics Inc. Completes Acquisition of BioServe India, a Premier Genomics and Next-Generation Sequencing Company investment picks
Shop and Support the Search for a Cure During the Annual PinkSTYLE Campaign GREENSBORO, N.C. , Sept.
Sign-up for Think Pink With Tanger Outlets And Help Fight Breast Cancer investment picks
SAN DIEGO and CHICAGO , June 30, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV) , the Robert H.
Sign-up for Trovagene Enters Into a Strategic Alliance with the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute investment picks
Grant to Support Research Examining Sleep and its Connection to Cancer OWINGS MILLS, Md.
Sign-up for Medifast Announces $100,000 Grant to The V Foundation for Cancer Research investment picks
2014/9/10
Siemens has exceeded its goal for The Baton Pass ™, a campaign designed to raise funds benefiting Stand Up To Cancer ® and increase awareness for cancer research at a time when they are critically needed.
Sign-up for Siemens Exceeds Goal of The Baton Pass™ Campaign – Donates Over $1 Million to Stand Up To Cancer® investment picks
SALT LAKE CITY, Sept.
Sign-up for Myriad Publishes myRisk Hereditary Cancer Study in Cancer investment picks
REDWOOD CITY, Calif., July 16, 2014 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED) , a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, today announced that patient dosing has begun in the randomized, placebo-controlled Phase 2 portion of the company's " ALPINE " ( A ntibody therapy in first- L ine P ancreatic cancer I nvestigating anti- N otch E fficacy and safety) clinical trial of its anti-Notch 2/3 cancer stem cell antibody, tarextumab (OMP-59R5), being studied for the treatment of pancreatic cancer.
Sign-up for OncoMed Pharmaceuticals Initiates Randomized Phase 2 "ALPINE" Clinical Trial of Tarextumab (Anti-Notch 2/3, OMP-59R5) for Pancreatic Cancer investment picks
2014/8/28
MasterCard & Stand Up To Cancer Canada Announce Exciting Collaboration in Support of Cancer Research in Canada Canada NewsWire TORONTO , Aug.
Sign-up for MasterCard & Stand Up To Cancer Canada Announce Exciting Collaboration in Support of Cancer Research in Canada investment picks
2014/9/3
Seventh Annual Sears National Kids Cancer Ride Raises Funds and Awareness for Children Living with and Beyond Cancer Canada NewsWire 18 Cyclists to ride coast to coast across Canada VANCOUVER , Sept.
Sign-up for Seventh Annual Sears National Kids Cancer Ride Raises Funds and Awareness for Children Living with and Beyond Cancer investment picks
3D Mammography Significantly Increases the Detection of Breast Cancer Concludes a Study that Reviewed Close to Half a Million Exams Published in the Journal of the American Medical Association (JAMA) Canada NewsWire Study using Hologic 3D Mammography systems is the largest to date involving 139 doctors from 13 U.S. academic and community-based sites BEDFORD, Mass.
Sign-up for 3D Mammography Significantly Increases the Detection of Breast Cancer Concludes a Study that Reviewed Close to Half a Million Exams Published in the Journal of the American Medical Association (JAMA) investment picks
Acquisition Adds Contracts With Five of the Top Biopharma Companies Globally Increases Overall Biopharma Contract Backlog to Over $18 Million Uniquely Positions CGI to Provide Genomic Testing Globally Including China, One of Fastest Growing Countries For Both Clinical Trials and Cancer Testing RUTHERFORD, N.J., July 21, 2014 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) , an emerging leader in DNA-based cancer diagnostics focused on developing genomic-based oncology tests and services, today announced the signing of a definitive agreement to acquire privately held Gentris Corporation, a global provider of clinical pharmacogenomics solutions, next-generation sequencing, and biomarker testing.
Sign-up for Cancer Genetics Announces Acquisition of Gentris Corporation, a Leading Global Pharmacogenomics Company, and Increases Contract Backlog to Over $18 Million investment picks
2014/8/6
Health Canada Approves ABRAXANE® Plus Gemcitabine for First-Line Treatment of Patients with Metastatic Pancreatic Cancer Canada NewsWire MISSISSAUGA, ON , August 6, 2014 /CNW/ - Health Canada has approved Pr ABRAXANE ® for Injectable Suspension (paclitaxel powder for injectable suspension) (nanoparticle, albumin-bound [nab ® ] paclitaxel) for first-line treatment of adult patients with metastatic pancreatic cancer.
Sign-up for Health Canada Approves ABRAXANE® Plus Gemcitabine for First-Line Treatment of Patients with Metastatic Pancreatic Cancer investment picks
2014/8/28
MasterCard's $250,000 Commitment Encourages Canadians to Stand Up To Cancer Canada NewsWire TORONTO , Aug.
Sign-up for MasterCard's $250,000 Commitment Encourages Canadians to Stand Up To Cancer investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Cancer Research
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Canadian Utilities  |  Next: Cancer Research Center